KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Return on Capital Employed (2016 - 2026)

Pacific Biosciences Of California has reported Return on Capital Employed over the past 15 years, most recently at 76.84% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 4004.0% year-over-year to 76.84%; the TTM value through Dec 2025 reached 76.84%, down 4004.0%, while the annual FY2025 figure was 58.34%, 2533.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 76.84% at Pacific Biosciences Of California, up from 88.63% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 9.92% in Q2 2021 and troughed at 88.63% in Q3 2025.
  • A 5-year average of 34.12% and a median of 20.23% in 2023 define the central range for Return on Capital Employed.
  • Biggest five-year swings in Return on Capital Employed: soared 16042bps in 2021 and later tumbled -6283bps in 2025.
  • Year by year, Return on Capital Employed stood at 9.92% in 2021, then crashed by -102bps to 20.08% in 2022, then increased by 4bps to 19.37% in 2023, then tumbled by -90bps to 36.8% in 2024, then tumbled by -109bps to 76.84% in 2025.
  • Business Quant data shows Return on Capital Employed for PACB at 76.84% in Q4 2025, 88.63% in Q3 2025, and 88.19% in Q2 2025.